An investigation of boron neutron capture therapy for recurrent glioblastoma multiforme

Acta Neurologica Scandinavica

Volumn 117, Issue 3, 2008, Pages 191-197

  Pellettieri, L ^a,b   H Stenstam, B ^c   Rezaei, A ^a,d   Giusti, V ^a,e   Skold K ^a  

^a Hammercap Medical AB   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c Nykoping Hospital   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

^e UNIVERSITY OF PISA   (Italy)

Author keywords

Boron neutron capture therapy; Boronophenylalanine; Recurrent glioblastoma; Survival; Toxicity

Indexed keywords

4 BORONOPHENYLALANINE FRUCTOSE; DRUG CARRIER; TEMOZOLOMIDE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GLIOBLASTOMA; HUMAN; MALE; NEUTRON CAPTURE THERAPY; PHOTON THERAPY; QUALITY OF LIFE; RADIATION DOSE; RADIATION FIELD; SURVIVAL TIME;

ADULT; AGED; BODY WEIGHT; BORON NEUTRON CAPTURE THERAPY; BRAIN NEOPLASMS; FEMALE; GLIOBLASTOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOTHERAPY DOSAGE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 38849129974     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2007.00924.x     Document Type: Article

References (15)

1. Capala J, H-Stenstam B, Sköld K et al. Boron neutron capture therapy for glioblastoma multiforme: clinical studies in Sweden. J Neurooncol 2003 62 : 135 44.
2. Stupp R, Mason WP, van den Bent MJ et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005 352 : 987 96.
3. Diaz AZ. Assessment of the results from the phase I/II boron neutron capture therapy trials at the Brookhaven National Laboratory from a clinician's point of view. J Neurooncol 2003 62 : 101 9.
4. H-Stenstam B, Pellettieri L, Sköld K, Rezaei A, Brun A Neuropathological postmortem evaluation of BNCT for GBM. Acta Neurol Scand In press 2007.
5. Coderre JA, Hopewell JW, Turcotte JC et al. Tolerance of normal human brain to boron neutron capture therapy. Appl Radiat Isot 2004 61 : 1083 7.
6. Schultheiss TE, Kun LE, Ang KK, Stephens LC. Radiation response of the central nervous system. Int J Radiat Oncol Biol Phys 1995 31 : 1093 112.
7. Flickinger JC, Kondziolka D, Lunsford LD et al. Development of a model to predict permanent symptomatic postradiosurgery injury for arteriovenous malformation patients. Int J Radiat Oncol Biol Phys 2000 46 : 1143 8.
8. Giusti V, Munck af Rosenschöld PM, Sköld K, Montagnini B, Capala J. Monte Carlo model of the Studsvik BNCT facility: description and validation. Med Phys 2003 30 : 3107 17.
9. Elowitz EH, Bergland RM, Coderre JA, Joel DD, Chadha M, Chanana AD. Biodistribution of p-boronophenylalanine in patients with glioblastoma multiforme for use in boron neutron capture therapy. Neurosurgery 1998 42 : 463 9.
10. Kankaanranta L, Havu K, Collan J et al. L-[18 F]F-BPA PET of gliomas and head and neck cancers [abstract]. Program of Eleventh World Congress on Neutron Capture Therapy, Boston, MA, USA, 11-15 October, 2004 30.
11. Nakagawa Y, Hatanaka H. Boron neutron capture therapy: Clinical brain tumor studies. J Neurooncol 1997 33 : 105 15.
12. Kankaanranta L, Kulvik M, Seppälä T et al. BPA Mediated BNCT in Gliomas in FiR 1 [abstract]. Program of Eleventh World Congress on Neutron Capture Therapy, Boston, MA, USA, 11-15 October, 2004 6.
13. Nieder C, Adam M, Molls M, Grosu AL. Therapeutic options for recurrent high-grade glioma in adult patients: Recent advances. Crit Rev Oncol Hematol 2006 60 : 181 93.
14. Brada M, Hoang-Xuan R, Rampling R et al. Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse. Ann Oncol 2001 12 : 259 66.
15. Groves MD, Puduvalli VK, Chang SM et al. A North American brain tumor consortium (NABTC 99-04) phase II trial of temozolomide plus thalidomide for recurrent glioblastoma multiforme. J Neurooncol 2007 81 : 271 7.